In this APAPP podcast, Kaitlyn Chapin, APRN, AGPCNP-BC, MSN, is joined by Sara Evans, MS, PA-C, discuss metabolic syndrome in patients with advanced lung disease and those undergoing lung transplantation. They review the key components of metabolic syndrome, including central obesity, impaired glucose metabolism, hypertension, elevated triglycerides, and reduced HDL cholesterol, while examining how these interconnected conditions may contribute to cardiovascular disease, diabetes, reduced lung function, and increased mortality.
This video explores metabolic syndrome screening and management before and after lung transplantation, including the limitations of BMI as a measure of body composition, the impact of obesity and sarcopenia on transplant candidacy, and the challenges of achieving weight loss in patients with severe respiratory limitations. Kaitlyn and Sara also discuss GLP-1 therapies, the metabolic effects of post-transplant immunosuppressive medications, and the importance of addressing cardiometabolic risk factors early and collectively. Ideal for pulmonology, advanced lung disease, and transplant providers, this discussion offers practical perspectives on improving long-term survival and quality of life for lung transplant patients.
Register to join us for the 4th Annual APAPP National Conference in New Orleans in 2027. For more expert-driven pulmonary education, visit the Pulm Hub and APAPP ACE app.
Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA
Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.com
Follow us on:
